You may also like
Vasopressor Therapy in Cardiac Surgery—An Experts’ Consensus Statement
The authors unanimously and weakly recommend that clinicians consider early addition of a second vasopressor (norepinephrine or vasopressin) if adequate vascular tone cannot be restored by a monotherapy with either norepinephrine or vasopressin and to consider using vasopressin as a first-line vasopressor or to add vasopressin to norepinephrine in cardiac surgical patients with pulmonary hypertension or right-sided heart dysfunction.
1 min read
In vitro Evaluation of Freeze-Dried Bone Allografts Combined With Platelet Rich Plasma and Human Bone Marrow Stromal Cells For Tissue Engineering
Freeze-dried bone allograft (FDBA) might be more effective in combination with platelet rich plasma (PRP) and bone marrow stromal cells (BMSC) in accelerating bone healing.
1 min read
Mortality Associated With Aprotinin During 5 Years Following Coronary Artery Bypass
To contrast long-term all-cause mortality in patients undergoing coronary artery bypass graft (CABG) surgery according to use of 2 lysine analog antifibrinolytics (aminocaproic acid and tranexamic acid), the serine protease inhibitor aprotinin, or no antibleeding agent.
1 min read